Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04655625
Recruitment Status : Active, not recruiting
First Posted : December 7, 2020
Last Update Posted : April 8, 2021
Japan Agency for Medical Research and Development
Information provided by (Responsible Party):
AnGes, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : April 2, 2021
Estimated Study Completion Date : March 31, 2022